Call for Papers
American Health & Drug Benefits (AHDB) offers an open forum for
all healthcare stakeholders to exchange ideas and present their needs, data, innovations,
and initiatives to facilitate patient-centered healthcare and benefit design models
that meet the needs of all stakeholders-Distributors, Employers, Evaluators, Manufacturers,
Patients, Payors, Providers, Purchasers, Regulators, and Researchers.
Readers are invited to submit articles that aim at improving the quality of the
US healthcare delivery system in general and of benefit design strategies in particular.
All articles will undergo a blind peer review, and acceptance is based on that review.
|
Areas of high interest include:
|
• Benefit Design Objectives
• Comparative-Effectiveness Analyses
• Decision-Making Tools
• Drug Trends
|
• Health Plan Initiatives
• Health Information Technology
• Innovation in Patient Care
• Off-label Use/Misuse
|
• Original Research
• Pharmacoeconomics
• Reimbursement Issues
• Surveys of Health Trends
|
Clinical topics of interest include:
Aging/dementia-With the aging of the US population, there is a growing need
for early implementation of proper diagnostic procedures, as well as outcome-based
preventive and therapeutic strategies for older people.
Allergies-Allergies, such as allergic or seasonal rhinitis, affect millions
of Americans daily, resulting in a significant economic burden and human cost. Undertreatment
and lack of adherence are common obstacles. In addition to new therapies, articles
should address issues of prevention, early diagnosis, and patient education programs.
Arthritis-Musculoskeletal conditions, such as rheumatoid arthritis or osteoporosis,
are on the increase, yet many patients are undiagnosed and untreated. Comparing
new and available therapies is a key target for improving patient outcomes and reducing
costs.
Cancer Therapy-The growing focus on biologic agents dictates an enhanced
study of these therapeutic options, including reimbursement policies, cost-management,
industry trends, and the biologic pipeline updates. Lung cancer presents major challenges
for early diagnosis and for improved therapeutic modalities.
Cardiovascular Disease-Still a leading cause of morbidity and mortality among
men and women, conditions such as atrial fibrillations, acute coronary syndrome,
and venous thromboembolism remain key to heart health. Original, outcome-based research
on appropriate therapies, diet, exercise, cost-comparisons, emerging prevention
strategies, and comparative-effectiveness of best practices will enhance readers'
decision-making.
Diabetes, Obesity-The increasing comorbid epidemics of these twin conditions
mandates a thorough examination of best therapies, adherence issues, access, and
prevention strategies. We invite articles that will address how to improve patient
outcomes and best individualized patient care.
Gastrointestinal conditions-Recognizing GI conditions, such as hepatitis
C, Crohn's disease, or inflammatory bowel disorder, remains a challenge. Evidence-based
articles dealing with best approach to management, as well as cost and reimbursement
issues, are highly desirable.
Infectious Diseases-The spread of common and emerging pathogens within the
hospital and in the community is a growing problem requiring increased vigilance.
Topics of interest include drug therapies, off-label uses, preventing medical errors,
and reimbursement.
Pain Management-Chronic pain is associated with a slew of complicated medical
disorders, such as fibromyalgia, and an enormous economic burden, yet pain medications,
such as opioids, are still underused. Articles should address best therapies, diagnosis,
and clinicians' anxiety about addiction issues and potential misuse.
Please submit manuscripts electronically to editorial@AHDBonline.com,
or mail to AHDB,
241 Forsgate Drive, Suite 205A, Jamesburg, NJ 08831. For inquiries about submissions,
call 732-992-1892.
